Qiagen INC:1110297 [22-005691]
Ended Awarded Last action
- Contract number
- 75N96022F00041
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
National Institute of Environmental Health Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,792
Award facts
- Contract value 100% obligated
- $11,792.32 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germantown, MD, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $11,792 |
About this award
Qiagen, LLC was awarded a Blanket Purchase Agreement (BPA) call valued at $11,792.32 by the National Institute of Environmental Health Sciences (NIESH) on April 20, 2022, with an ultimate completion date of May 18, 2022. This firm fixed-price contract represents a call against a larger $10 million BPA that NIESH maintains with Qiagen for medical and scientific equipment and biological materials. The work will be performed in Germantown, Maryland, and no set-aside designation was applied to this award. Qiagen, LLC is a foreign-owned subsidiary of Qiagen N.V., a multinational biotechnology company headquartered in the Netherlands, and specializes in molecular diagnostics, sample preparation systems, and bioinformatics solutions.
Under this BPA call, Qiagen will supply molecular diagnostics products, reagents, consumables, or related scientific equipment to support NIESH's research and environmental health initiatives. The company's federal contract portfolio demonstrates consistent capability in delivering specialized laboratory instrumentation such as QIAsymphony and QIAcube systems, DNA/RNA extraction kits, and diagnostic testing reagents to multiple federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans Affairs. This award reflects Qiagen's established position in the federal marketplace as a qualified provider of advanced molecular biology products and services to civilian health and research agencies.
Quick answers
Who was awarded contract 75N96022F00041?
75N96022F00041 was awarded to Qiagen, LLC by National Institute of Environmental Health Sciences (National Institutes of Health) on April 20, 2022.
How much is contract 75N96022F00041 worth?
The government has obligated $11,792 on 75N96022F00041.
Is contract 75N96022F00041 an order under another contract?
Yes. 75N96022F00041 is a BPA call under HHSN263201500079B, a blanket purchase agreement.
Was contract 75N96022F00041 competed?
The extent of competition for 75N96022F00041 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award